Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 1, 2021 | C2i Genomics | $100.0M Series B | Casdin Capital | Album VC, NFX, Alexandria Venture Investments, Driehaus Capital Management, Duquesne Family Office, iGlobe Partners, LionBird, NFX, Section 32, Silver Lake, The Mark Foundation for Cancer Research |